The ‘diplomatic’ and ‘passionate’ team at Baker McKenzie CVBA/SCRL leverages the firm’s international network to assist its broad client base with disputes concerning tenders, corporate financing issues, and competition issues involving pricing. Els Janssens and Roel Meers jointly lead the team. Janssens advises numerous clients in the medical device, pharmaceutical, and health services industries, primarily focusing on assisting industry associations with EU policy. Meers is noted for his transactional experience within the Benelux biotech and healthtech markets, where he often advises clients on corporate finance and capital markets transactions. Elisabeth Dehareng maintains a technology and IP focused practice, with particular emphasis on data protection and privacy in the healthcare sector.
Testimonials
Collated independently by Legal 500 research team.
‘Great knowledge of the specificities of the pharmaceutical industry.’
‘Roel Meers is always available, pragmatic, he is business minded and has a solution oriented approach.’
- ‘Els Janssens stands out for her regulatory expertise.’
‘Knowledge and expertise, commitment, excellent service, very good collaboration within the team.’
‘The team has very good understanding, not only in theory but through practical experience. Very committed, kind, very clear concerning solutions but also at the same time diplomatic and passionate. The team has experience in dealing with authorities which makes it unique.’
Key clients
- Abbott
- Abbvie
- Acorda Therapeutics
- Agomab Therapeutics
- Astellas
- Baxter
- Becton Dickinson
- BVI Medical
- Cochlear
- CSL Behring
- EFPIA
- Embecta
- Engrail Therapeutics
- European Medicines Verification Organization EMVO
- Ferring
- Galapagos
- GSK
- Hyland
- ICU Medical
- Inari Medical
- Intuitive Surgical
- Johnson & Johnson
- Karl Storz
- MDxHealth SA
- Menarini Operations Luxembourg SA
- Phardiag Ltd
- Laboratorios Menarini SA
- Menarini France SA
- Merit Medical
- Microport
- Mithra Pharmaceuticals
- MSD
- Neurocrine Bioscience
- Octa Pharma
- Opentrons
- PTC Therapeutics
- Regeneron
- Sequana Medical NV
- Seqirus
- Siemens Healthcare
- Tecan
- Vaccines Europe
- Xenon Pharmaceuticals
- Unilabs
Work highlights
- Advised Mithra Pharmaceuticals on its senior secured convertible facilities agreement with funds managed by Highbridge Capital Management, LLC and funds managed by Whitebox Advisors LLC, for a three year term, in an amount of up to €100m.
- Advised Biocartis Group on its comprehensive recapitalisation.
- Advised MDxHealth on its $100m acquisition of the Oncotype DX®GPS (Genomic Prostate Score®) test from Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, and the financing of the acquisition through an up to $70m loan and security agreement with an affiliate of Innovatus Capital Partners, LLC.
Practice head
The lawyer(s) leading their teams.
Els Janssens, Roel Meers